These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1600772)

  • 1. Utilization of acute bronchodilator responses in stable COPD to predict the relative efficacy of individual agents.
    Peacock MD; Johnson JE
    Chest; 1992 Jun; 101(6):1552-7. PubMed ID: 1600772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group.
    Casaburi R; Briggs DD; Donohue JF; Serby CW; Menjoge SS; Witek TJ
    Chest; 2000 Nov; 118(5):1294-302. PubMed ID: 11083677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease.
    Hadcroft J; Calverley PM
    Thorax; 2001 Sep; 56(9):713-20. PubMed ID: 11514693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures of bronchodilator response of FEV
    Torén K; Bake B; Olin AC; Engström G; Blomberg A; Vikgren J; Hedner J; Brandberg J; Persson HL; Sköld CM; Rosengren A; Bergström G; Janson C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():973-980. PubMed ID: 28356729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute bronchodilator trials in chronic obstructive pulmonary disease.
    Nisar M; Earis JE; Pearson MG; Calverley PM
    Am Rev Respir Dis; 1992 Sep; 146(3):555-9. PubMed ID: 1387772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term study of symptoms, spirometry and survival amongst home nebulizer users.
    O'Driscoll BR; Bernstein A
    Respir Med; 1996 Oct; 90(9):561-6. PubMed ID: 8984531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.
    Mahler DA; Waterman LA; Ward J; Gifford AH
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):103-9. PubMed ID: 23745526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease.
    Hay JG; Stone P; Carter J; Church S; Eyre-Brook A; Pearson MG; Woodcock AA; Calverley PM
    Eur Respir J; 1992 Jun; 5(6):659-64. PubMed ID: 1628722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled beta 2-agonist in the treatment of stable COPD?
    Nishimura K; Koyama H; Ikeda A; Izumi T
    Chest; 1993 Jul; 104(1):179-84. PubMed ID: 8325065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bronchodilator test with increasing doses of terbutaline in chronic obstructive pulmonary disease patients.
    Rodríguez-Carballeira M; Heredia JL; Rué M; Quintana S; Gómez L
    Pulm Pharmacol Ther; 2001; 14(1):61-5. PubMed ID: 11162421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of bronchodilator efficacy in symptomatic COPD: is spirometry useful?
    O'Donnell DE
    Chest; 2000 Feb; 117(2 Suppl):42S-7S. PubMed ID: 10673474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.
    Newnham DM; Dhillon DP; Winter JH; Jackson CM; Clark RA; Lipworth BJ
    Thorax; 1993 Nov; 48(11):1151-5. PubMed ID: 8296260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
    Pillet O; Manier G; Castaing Y
    Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute postbronchodilator changes in pulmonary function parameters in patients with chronic airways obstruction.
    Berger R; Smith D
    Chest; 1988 Mar; 93(3):541-6. PubMed ID: 3223980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of six different ways of expressing the bronchodilating response in asthma and COPD; reproducibility and dependence of prebronchodilator FEV1.
    Dompeling E; van Schayck CP; Molema J; Akkermans R; Folgering H; van Grunsven PM; van Weel C
    Eur Respir J; 1992 Sep; 5(8):975-81. PubMed ID: 1426206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group.
    Chest; 1997 Dec; 112(6):1514-21. PubMed ID: 9404747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.